Perseus Proteomics, Inc. (JP:4882) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Perseus Proteomics, Inc. recently showcased promising results for their radioisotope labeled antibody, PPMX-T002, at the EANM ’24 Congress in Germany. The antibody, designed to target cadherin 3 expressed in various solid tumors, demonstrated enhanced efficacy in preclinical trials when utilizing Actinium 225 over Yttrium 90. This development signals a potential breakthrough in cancer treatment strategies.
For further insights into JP:4882 stock, check out TipRanks’ Stock Analysis page.